Cited by 1,597Cancer Genomics and DiagnosticsGenomics and Rare DiseasesChromatin Remodeling and Cancer

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Open access

Sondka, Zbyslaw, Bamford, Sally, Cole, Charlotte G., Ward, Sari A., Dunham, Ian, Forbes, Simon A.·2018·Nature Reviews Cancer

DOI 10.1038/s41568-018-0060-1PMC PMC6450507

Open this paper in CoChat — free account

Abstract

The Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC) is an expert-curated description of the genes driving human cancer that is used as a standard in cancer genetics across basic research, medical reporting and pharmaceutical development. After a major expansion and complete re-evaluation, the 2018 CGC describes in detail the effect of 719 cancer-driving genes. The recent expansion includes functional and mechanistic descriptions of how each gene contributes to disease generation in terms of the key cancer hallmarks and the impact of mutations on gene and protein function. These functional characteristics depict the extraordinary complexity of cancer biology and suggest multiple cancer-related functions for many genes, which are often highly tissue-dependent or tumour stage-dependent. The 2018 CGC encompasses a second tier, describing an expanding list of genes (currently 145) from more recent cancer studies that show supportive but less detailed indications of a role in cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41568-018-0060-1

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cancer Genome Landscapes
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
Wnt signaling in cancer
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517

Show all 102 references

Sorted by citations

COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Self-citation
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., Qin, S., Zhang, L., Ouyang, H., Du, P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.010 · Cited by 1,601
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,340
Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
Yamanaka, S. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.09.014 · Cited by 1,268
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data
Ianevski, A., Giri, A. K., & Aittokallio, T. A. (2022) · Nature Communications · doi:10.1038/s41467-022-28803-w · Cited by 787
Small molecules, big impact: 20 years of targeted therapy in oncology
Bedard, P. L., Hyman, D. M., Davids, M. S., & Siu, L. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30164-1 · Cited by 637
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
Yang, Z., Yan, C., Ma, J., Peng, P., Ren, X., Cai, S., Shen, X., Wu, Y. C., Zhang, S., Wang, X., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00710-w · Cited by 629
Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.005 · Cited by 581
COSMIC: a curated database of somatic variants and clinical data for cancer
Sońdka, Z., Bindal, N., Carvalho‐Silva, D., Jupe, S., Madhumita, McLaren, K., Starkey, M., Ward, S. A., Wilding, J. L., Ahmed, M., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad986 · Cited by 565
Self-citation
Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation
Tanaka, N., Lin, J. J., Li, C., Ryan, M. B., Zhang, J., Kiedrowski, L. A., Michel, A. G., Syed, M. U., Fella, K. A., Sakhi, M., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0365 · Cited by 527
Open Targets Platform: supporting systematic drug–target identification and prioritisation
Ochoa, D., Hercules, A., Carmona, M., Süveges, D., Gonzalez‐Uriarte, A., Malangone, C., Miranda, A., Fumis, L., Carvalho‐Silva, D., Spitzer, M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1027 · Cited by 487
Self-citation
In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice
Koblan, L. W., Erdos, M. R., Wilson, C., Cabral, W. A., Levy, J. M., Xiong, Z., Tavarez, U. L., Davison, L. M., Gete, Y. G., Mao, X., et al. (2021) · Nature · doi:10.1038/s41586-020-03086-7 · Cited by 489
Open Targets Platform: new developments and updates two years on
Carvalho‐Silva, D., Pierleoni, A., Pignatelli, M., Ong, C. K., Fumis, L., Karamanis, N., Carmona, M., Faulconbridge, A., Hercules, A., McAuley, E., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1133 · Cited by 453
Self-citation
Biologically informed deep neural network for prostate cancer discovery
Elmarakeby, H. A., Hwang, J., Arafeh, R., Crowdis, J., Gang, S., Liu, D., AlDubayan, S. H., Salari, K., Kregel, S., Richter, C., et al. (2021) · Nature · doi:10.1038/s41586-021-03922-4 · Cited by 456
The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer
Wander, S. A., Cohen, O., Gong, X., Johnson, G. N., Buendia-Buendia, J. E., Lloyd, M. R., Kim, D., Luo, F., Mao, P., Helvie, K. E., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1390 · Cited by 447
The genomics of oxidative DNA damage, repair, and resulting mutagenesis
Poetsch, A. R. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.013 · Cited by 420
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Dong, L., Lu, D., Chen, R., Lin, Y., Zhu, H., Zhang, Z., Cai, S., Cui, P., Song, G., Rao, D., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.12.006 · Cited by 410
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Wong, M., Mayoh, C., Lau, L. M. S., Khuong-Quang, D.-A., Pinese, M., Kumar, A., Barahona, P., Wilkie, E. E., Sullivan, P. A., Bowen-James, R., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1072-4 · Cited by 394
The genomic landscape of pediatric acute lymphoblastic leukemia
Brady, S. W., Roberts, K. G., Gu, Z., Shi, L. G., Pounds, S. B., Pei, D., Cheng, C., Dai, Y. E., Devidas, M., Qu, C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01159-z · Cited by 413
A proteogenomic portrait of lung squamous cell carcinoma
Satpathy, S., Krug, K., Beltran, P. M. J., Savage, S. R., Petralia, F., Kumar‐Sinha, C., Dou, Y., Reva, B. A., Kane, M. H., Avanessian, S. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.016 · Cited by 390
A cross-disorder dosage sensitivity map of the human genome
Collins, R. L., Glessner, J., Porcu, E., Lepamets, M., Brandon, R. C., Lauricella, C., Han, L., Morley, T. J., Niestroj, L., Ulirsch, J. C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.036 · Cited by 369
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
Barroso‐Sousa, R., Jain, E., Cohen, O., Kim, D., Buendia-Buendia, J. E., Winer, E. P., Lin, N., Tolaney, S. M., & Wagle, N. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.11.010 · Cited by 370
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Gangoso, E., Southgate, B., Bradley, L., Lehr, S., Gálvez‐Cancino, F., McGivern, N., Güç, E., Kapourani, C.-A., Byron, A., Ferguson, K. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.023 · Cited by 365
Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
Doi, D., Magotani, H., Kikuchi, T., Ikeda, M., Hiramatsu, S., Yoshida, K., Amano, N., Nomura, M., Umekage, M., Morizane, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17165-w · Cited by 350
A genomic and epigenomic atlas of prostate cancer in Asian populations
Li, J., Xu, C., Lee, H. J., Ren, S., Zi, X., Zhang, Z., Wang, H., Yu, Y., Yang, C., Gao, X., et al. (2020) · Nature · doi:10.1038/s41586-020-2135-x · Cited by 353
Functional Enhancers Shape Extrachromosomal Oncogene Amplifications
Morton, A. R., Dogan-Artun, N., Faber, Z. J., MacLeod, G. D. A. H., Bartels, C. F., Piazza, M. S., Allan, K. C., Mack, S. C., Wang, X., Gimple, R. C., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.039 · Cited by 336
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Néou, M., Villa, C., Armignacco, R., Jouinot, A., Raffin‐Sanson, M., Septier, A., Letourneur, F., Diry, S., Diedisheim, M., Izac, B., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.11.002 · Cited by 352
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Xiao, Y., Ma, D., Yang, Y., Yang, F., Ding, J.-H., Gong, Y., Jiang, L., Ge, L., Wu, S., Yu, Q., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00614-0 · Cited by 336
The mutational footprints of cancer therapies
Pich, O., Muiños, F., Lolkema, M. P., Steeghs, N., Gonzalez-Perez, A., & Lopez-Bigas, N. (2019) · Nature Genetics · doi:10.1038/s41588-019-0525-5 · Cited by 309
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
Ali, H. R., Jackson, H. W., Zanotelli, V. R., Danenberg, E., Fischer, J. R., Bardwell, H. A., Provenzano, E., CRUK IMAXT Grand Challenge Team, Ali, H. R., Sa’d, M. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0026-6 · Cited by 313
Genetic and non-genetic clonal diversity in cancer evolution
Black, J. R., & McGranahan, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00336-2 · Cited by 298
Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features
Buisson, R., Langenbucher, A., Bowen, D., Kwan, E. E., Benes, C. H., Zou, L., & Lawrence, M. S. (2019) · Science · doi:10.1126/science.aaw2872 · Cited by 318
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs
Hadi, K., Yao, X., Behr, J. M., Deshpande, A. S., Xanthopoulakis, C., Tian, H., Kudman, S., Rosiene, J. A., Darmofal, M., DeRose, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.006 · Cited by 249
Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms
Schulte-Sasse, R., Budach, S., Hnisz, D., & Marsico, A. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00325-y · Cited by 274
Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes
Wei, W., Schon, K. R., Elgar, G., Orioli, A., Tanguy, M., Giess, A. P., Tischkowitz, M. D., Caulfield, M. J., & Chinnery, P. F. (2022) · Nature · doi:10.1038/s41586-022-05288-7 · Cited by 262
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
Zeng, D., Wu, J., Luo, H., Li, Y., Xiao, J., Peng, J., Ye, Z., Zhou, R., Yu, Y., Wang, G., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002467 · Cited by 236
Genetic and epigenetic characteristics of inflammatory bowel disease-associated colorectal cancer
Rajamäki, K., Taira, A., Katainen, R., Välimäki, N., Kuosmanen, A., Plaketti, R.-M., Seppälä, T. T., Ahtiainen, M., Wirta, E.-V., Vartiainen, E., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.042 · Cited by 230
Cancer Genome Evolutionary Trajectories in Metastasis
Birkbak, N. J., & McGranahan, N. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.004 · Cited by 223
The origins and genetic interactions of KRAS mutations are allele- and tissue-specific
Cook, J. H., Melloni, G. E. M., Gulhan, D. C., Park, P. J., & Haigis, K. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22125-z · Cited by 208
SIGNOR 2.0, the SIGnaling Network Open Resource 2.0: 2019 update
Licata, L., Surdo, P. L., Iannuccelli, M., Palma, A., Micarelli, E., Perfetto, L., Peluso, D., Calderone, A., Castagnoli, L., & Cesareni, G. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz949 · Cited by 206
An analysis of genetic heterogeneity in untreated cancers
Reiter, J. G., Baretti, M., Gerold, J. M., Makohon-Moore, A. P., DAUD, A. I., Iacobuzio–Donahue, C. A., Azad, N. S., Kinzler, K. W., Nowak, M. A., & Vogelstein, B. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0185-x · Cited by 213
Cancer gene mutation frequencies for the U.S. population
Mendiratta, G., Ke, E., Aziz, M., Liarakos, D., Tong, M. M., & Stites, E. C. (2021) · Nature Communications · doi:10.1038/s41467-021-26213-y · Cited by 225
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Geffen, Y., Anand, S. K., Akiyama, Y., Yaron, T. M., Song, Y., Johnson, J. L., Govindan, A., Babur, Ö., Li, Y., Huntsman, E. M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.013 · Cited by 217
Subtype-specific 3D genome alteration in acute myeloid leukaemia
Xu, J., Song, F., Lyu, H., Kobayashi, M., Zhang, B., Zhao, Z., Hou, Y., Wang, X., Luan, Y., Jia, B., et al. (2022) · Nature · doi:10.1038/s41586-022-05365-x · Cited by 208
Spatial biology of cancer evolution
Seferbekova, Z., Lomakin, A., Yates, L. R., & Gerstung, M. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00553-x · Cited by 227
Cancer biomarker discovery and translation: proteomics and beyond
Hristova, V. A., & Chan, D. W. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1559062 · Cited by 203
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
PDXNET Consortium, Woo, X. Y., EurOPDX Consortium, Giordano, J., Srivastava, A., Zhao, Z.-M., Lloyd, M. W., de Bruijn, R., Suh, Y.-S., Patidar, R., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00750-6 · Cited by 190
Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
Maenhoudt, N., Defraye, C., Boretto, M., Jan, Z., Heremans, R., Boeckx, B., Hermans, F., Arijs, I., Cox, B., Van Nieuwenhuysen, E., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.004 · Cited by 186
Tumour predisposition and cancer syndromes as models to study gene–environment interactions
Carbone, M., Arron, S. T., Beutler, B., Bononi, A., Cavenee, W., Cleaver, J. E., Croce, C. M., D’Andrea, A., Foulkes, W. D., Gaudino, G., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0265-y · Cited by 147
DriverDBv3: a multi-omics database for cancer driver gene research
Liu, S., Shen, P.-C., Chen, C., Hsu, A.-N., Cho, Y.-C., Lai, Y.-L., Chen, G. T. Y., Li, C., Wang, S., Chen, M., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz964 · Cited by 183
Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Robinson, P. S., Coorens, T. H. H., Palles, C., Mitchell, E., Abascal, F., Olafsson, S., Lee, B. C. H., Lawson, A. R. J., Lee-Six, H., Moore, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00930-y · Cited by 173
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180
Re-definition of claudin-low as a breast cancer phenotype
Fougner, C., Bergholtz, H., Norum, J. H., & Sørlie, T. (2020) · Nature Communications · doi:10.1038/s41467-020-15574-5 · Cited by 175
Geographic and age variations in mutational processes in colorectal cancer
Díaz‐Gay, M., dos Santos, W., Moody, S., Kazachkova, M., Abbasi, A., Steele, C. D., Vangara, R., Senkin, S., Wang, J., Fitzgerald, S., et al. (2025) · Nature · doi:10.1038/s41586-025-09025-8 · Cited by 204
NPInter v4.0: an integrated database of ncRNA interactions
Teng, X., Chen, X., Xue, H., Tang, Y., Zhang, P., Kang, Q., Hao, Y., Chen, R., Zhao, Y. C., & He, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz969 · Cited by 174
First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol
Sugai, K., Sumida, M., Shofuda, T., Yamaguchi, R., Tamura, T., Kohzuki, T., Abe, T., Shibata, R., Kamata, Y., Ito, S., et al. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.08.005 · Cited by 179
Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA
Bergstrom, E. N., Luebeck, J., Petljak, M., Khandekar, A., Barnes, M. D., Zhang, T., Steele, C. D., Pillay, N., Landi, M. T., Bafna, V., et al. (2022) · Nature · doi:10.1038/s41586-022-04398-6 · Cited by 166
Polygenic architecture of rare coding variation across 394,783 exomes
Weiner, D. J., Nadig, A., Jagadeesh, K. A., Dey, K. K., Neale, B. M., Robinson, E., Karczewski, K. J., & O’Connor, L. J. (2023) · Nature · doi:10.1038/s41586-022-05684-z · Cited by 168
Local Determinants of the Mutational Landscape of the Human Genome
González-Pérez, A., Sabarinathan, R., & López-Bigas, N. (2019) · Cell · doi:10.1016/j.cell.2019.02.051 · Cited by 172
SIGNOR 3.0, the SIGnaling network open resource 3.0: 2022 update
Surdo, P. L., Iannuccelli, M., Contino, S., Castagnoli, L., Licata, L., Cesareni, G., & Perfetto, L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac883 · Cited by 161
Prognostic genome and transcriptome signatures in colorectal cancers
Nunes, L., Li, F., Wu, M., Luo, T., Hammarström, K., Torell, E., Ljuslinder, I., Mezheyeuski, A., Edqvist, P.-H. D., Löfgren‐Burström, A., et al. (2024) · Nature · doi:10.1038/s41586-024-07769-3 · Cited by 179
A novel canine reference genome resolves genomic architecture and uncovers transcript complexity
Wang, C., Wallerman, O., Arendt, M. L., Sundström, E., Karlsson, Å., Nordin, J., Mäkeläinen, S., Pielberg, G., Hanson, J., Ohlsson, Å., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01698-x · Cited by 176
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Knisbacher, B. A., Lin, Z., Hahn, C. K., Nadeu, F., Duran‐Ferrer, M., Stevenson, K. E., Tausch, E., Delgado, J., Barbera-Mourelle, A., Taylor-Weiner, A. N., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01140-w · Cited by 167
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
on behalf of the International CML Foundation Genomics Alliance, Branford, S., Kim, D. D. H., Apperley, J. F., Eide, C. A., Mustjoki, S., Ong, S. T., Nteliopoulos, G., Ernst, T., Chuah, C., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0512-y · Cited by 149
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
Bazzichetto, C., Conciatori, F., Pallocca, M., Falcone, I., Fanciulli, M., Cognetti, F., Milella, M., & Ciuffreda, L. (2019) · Cancers · doi:10.3390/cancers11040435 · Cited by 151
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
Jiang, Y., Wang, J., Sun, M., Zuo, D., Wang, H., Shen, J., Jiang, W., Mu, H., Ma, X., Yin, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34689-5 · Cited by 159
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer
Cotto, K. C., Feng, Y.-Y., Ramu, A., Richters, M. M., Freshour, S. L., Skidmore, Z. L., Xia, H., McMichael, J. F., Kunisaki, J., Campbell, K. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37266-6 · Cited by 179
Polysaccharides of mushroom Pleurotus spp.: New extraction techniques, biological activities and development of new technologies
Barbosa, J. R., Freitas, M. M. D. S., Martins, L. H. D. S., & de Carvalho, R. N. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115550 · Cited by 129
In silico saturation mutagenesis of cancer genes
Muiños, F., Martínez-Jiménez, F., Pich, O., González-Pérez, A., & López-Bigas, N. (2021) · Nature · doi:10.1038/s41586-021-03771-1 · Cited by 125
GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction
Liu, X., Song, C., Huang, F. F., Fu, H., Xiao, W., & Zhang, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab457 · Cited by 127
CancerSCEM: a database of single-cell expression map across various human cancers
Zeng, J., Zhang, Y., Shang, Y., Mai, J., Shi, S., Lu, M., Bu, C., Zhang, Z., Zhang, Z., Li, Y., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab905 · Cited by 126
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Bakouny, Z., Sadagopan, A., Ravi, P. K., Metaferia, N. Y., Li, J., AbuHammad, S., Tang, S., Denize, T., Garner, E. R., Gao, X. Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110190 · Cited by 123
Mutational landscape of cancer-driver genes across human cancers
Sinkala, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-39608-2 · Cited by 154
Fitness variation across subtle environmental perturbations reveals local modularity and global pleiotropy of adaptation
Kinsler, G., Geiler‐Samerotte, K., & Petrov, D. A. (2020) · eLife · doi:10.7554/elife.61271 · Cited by 114
Clinical Application of Cytokines in Cancer Immunotherapy
Qiu, Y., Su, M., Liu, L., Tang, Y., Pan, Y., & Sun, J. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s308578 · Cited by 123
Molecular classification of hormone receptor-positive HER2-negative breast cancer
Jin, X., Zhou, Y.-F., Ma, D., Zhao, S., Lin, C., Xiao, Y., Fu, T., Liu, C., Chen, Y., Xiao, W.-X., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01507-7 · Cited by 118
Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma
Megquier, K., Turner-Maier, J., Swofford, R., Kim, J. H., Sarver, A. L., Wang, C., Sakthikumar, S., Johnson, J., Koltookian, M., Lewellen, M., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0221 · Cited by 120
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin
Tedesco, M., Giannese, F., Lazarević, D., Giansanti, V., Rosano, D., Monzani, S., Catalano, I., Grassi, E., Zanella, E. R., Botrugno, O. A., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01031-1 · Cited by 114
Cross-species oncogenic signatures of breast cancer in canine mammary tumors
Kim, T., Yang, I. S., Seung, B., Lee, S., Kim, D., Ha, Y.-J. J., Seo, M.-K., Kim, K.-K., Kim, H. S., Cheong, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17458-0 · Cited by 116
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data
Tian, L., Li, Y., Edmonson, M. N., Zhou, X., Newman, S., McLeod, C., Thrasher, A., Liu, Y., Tang, B., Rusch, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02043-x · Cited by 113
Comparative assessment of genes driving cancer and somatic evolution in non-cancer tissues: an update of the Network of Cancer Genes (NCG) resource
Dreßler, L., Bortolomeazzi, M., Keddar, M. R., Mišetić, H., Sartini, G., Acha‐Sagredo, A., Montorsi, L., Wijewardhane, N., Repana, D., Nulsen, J., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02607-z · Cited by 119
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Li, Y., Porta‐Pardo, E., Tokheim, C. J., Bailey, M. H., Yaron, T. M., Stathias, V., Geffen, Y., Imbach, K. J., Cao, S., Anand, S. K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.014 · Cited by 124
New insight into circRNAs: characterization, strategies, and biomedical applications
Feng, X., Zhu, S.-X., Pu, K., Huang, H., Chen, Y., & Wang, W. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00451-w · Cited by 119
De novo detection of somatic mutations in high-throughput single-cell profiling data sets
Muyas, F., Sauer, C. M., Valle-Inclán, J. E., Li, R., Rahbari, R., Mitchell, T. J., Hormoz, S., & Cortés‐Ciriano, I. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01863-z · Cited by 125
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities
Nichols, C. A., Gibson, W. J., Brown, M. S., Kosmicki, J. A., Busanovich, J. P., Wei, H. Y., Urbanski, L. M., Currimjee, N., Berger, A. C., Gao, G. F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16399-y · Cited by 107
Transcriptional effects of copy number alterations in a large set of human cancers
Bhattacharya, A., Bense, R. D., Urzúa-Traslaviña, C. G., de Vries, E. G. E., van Vugt, M. A. T. M., & Fehrmann, R. S. N. (2020) · Nature Communications · doi:10.1038/s41467-020-14605-5 · Cited by 102
Linking pollution and cancer in aquatic environments: A review
Baines, C., Lerebours, A., Frédéric Thomas, A., Fort, J., Kreitsberg, R., Gentès, S., Meitern, R., Saks, L., Újvári, B., Giraudeau, M., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106391 · Cited by 105
The concurrence of DNA methylation and demethylation is associated with transcription regulation
Shi, J., Xu, J., Chen, Y. E., Li, J. S., Cui, Y., Shen, L., Li, J. J., & Li, W. (2021) · Nature Communications · doi:10.1038/s41467-021-25521-7 · Cited by 102
Comprehensive analysis of structural variants in breast cancer genomes using single-molecule sequencingPreprint
Aganezov, S. S., Goodwin, S., Sherman, R. M., Sedlazeck, F. J., Arun, G., Bhatia, S., Lee, I., Kirsche, M., Wappel, R. L., Kramer, M., et al. (2020) · Genome Research · doi:10.1101/gr.260497.119 · Cited by 104
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups
Egan, C., Nicolae, A., Lack, J., Chung, H., Skarshaug, S., Pham, T., Navarro, W., Abdullaev, Z., Aguilera, N. S. I., Xi, L., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.230375 · Cited by 104
CysDB: a human cysteine database based on experimental quantitative chemoproteomics
Boatner, L. M., Palafox, M. F., Schweppe, D. K., & Backus, K. M. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.04.004 · Cited by 99
Discovering the drivers of clonal hematopoiesis
Pich, O., Reyes-Salazar, I., González-Pérez, A., & López-Bigas, N. (2022) · Nature Communications · doi:10.1038/s41467-022-31878-0 · Cited by 100
Annotating and prioritizing genomic variants using the Ensembl Variant Effect Predictor—A tutorial
Hunt, S. E., Moore, B., Amode, R., Armean, I. M., Lemos, D., Mushtaq, A., Parton, A., Schuilenburg, H., Szpak, M., Thormann, A., et al. (2021) · Human Mutation · doi:10.1002/humu.24298 · Cited by 96
Cancer aneuploidies are shaped primarily by effects on tumour fitness
Shih, J., Sarmashghi, S., Zhakula-Kostadinova, N., Zhang, S., Georgis, Y., Hoyt, S. H., Cuoco, M. S., Gao, G. F., Spurr, L. F., Berger, A. C., et al. (2023) · Nature · doi:10.1038/s41586-023-06266-3 · Cited by 108
RosettaDDGPrediction for high‐throughput mutational scans: From stability to binding
(2022) · doi:10.1002/pro.4527 · Cited by 90
Cell-type-specific analysis of alternative polyadenylation using single-cell transcriptomics data
Shulman, E. D., & Elkon, R. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz781 · Cited by 93
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients
Nagashima, T., Yamaguchi, K., Urakami, K., Shimoda, Y., Ohnami, S., Ohshima, K., TANABE, T., Naruoka, A., Kamada, F., Serizawa, M., et al. (2019) · Cancer Science · doi:10.1111/cas.14290 · Cited by 98
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
Chen, H., Deng, C., Gao, J., Wang, J., Fu, F., Wang, Q., Wang, Q., Zhang, S., Zhang, S., Fan, F., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.01.012 · Cited by 98
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes
Bolton, K. L., Chen, D., Corona, R. I., Fu, Z., Murali, R., Köbel, M., Tazi, Y., Cunningham, J. M., Chan, I. C. C., Wiley, B. J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3817 · Cited by 93

Authors: Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A.
Affiliations: Wellcome Sanger Institute (GB)
European Bioinformatics Institute (GB)
ORCID: Dunham, Ian
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2018-10-06
Volume: 18
Issue: 11
Pages: 696-705
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-018-0060-1
PMC: PMC6450507
OpenAlex: W2894573839
Cited by: 1,597
References: 102
Citations by year: 2026: 125 · 2025: 227 · 2024: 242 · 2023: 239 · 2022: 260 · 2021: 250 · 2020: 167 · 2019: 75 · 2018: 8
FWCI: 13.23
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: somatic mutations, cancer genetics, gene function, cancer hallmarks, expert curation, cancer genomics
MeSH terms: Humans, Mutation, Neoplasms, Censuses

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks